97 related articles for article (PubMed ID: 16014228)
1. [Gallstones as symptoms of cholecystokinin resistance].
Rehfeld JF; Gøtze JP
Ugeskr Laeger; 2005 Jun; 167(24):2658-9. PubMed ID: 16014228
[No Abstract] [Full Text] [Related]
2. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for
Wang HH; Portincasa P; Liu M; Tso P; Wang DQ
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260332
[TBL] [Abstract][Full Text] [Related]
3. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.
Wang HH; Portincasa P; Wang DQ
Curr Med Chem; 2019; 26(19):3407-3423. PubMed ID: 28625150
[TBL] [Abstract][Full Text] [Related]
4. Correlation between gene expression of CCK-A receptor and emptying dysfunction of the gallbladder in patients with gallstones and diabetes mellitus.
Ding X; Lu CY; Mei Y; Liu CA; Shi YJ
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):295-8. PubMed ID: 15908333
[TBL] [Abstract][Full Text] [Related]
5. Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.
Wang HH; Liu M; Portincasa P; Tso P; Wang DQ
Neurogastroenterol Motil; 2016 Mar; 28(3):364-75. PubMed ID: 26604077
[TBL] [Abstract][Full Text] [Related]
6. Gallbladder motor function, plasma cholecystokinin and cholecystokinin receptor of gallbladder in cholesterol stone patients.
Zhu J; Han TQ; Chen S; Jiang Y; Zhang SD
World J Gastroenterol; 2005 Mar; 11(11):1685-9. PubMed ID: 15786550
[TBL] [Abstract][Full Text] [Related]
7. [An investigation of the relationship of gallbladder motility and gallstone formation in patients with liver cirrhosis].
Hao RR; Wang HJ; Jia JD; Li CL
Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):137-8. PubMed ID: 16494788
[No Abstract] [Full Text] [Related]
8. Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease.
Wang HH; Liu M; Li X; Portincasa P; Wang DQ
Eur J Clin Invest; 2017 Apr; 47(4):328-333. PubMed ID: 28186337
[TBL] [Abstract][Full Text] [Related]
9. Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous "black" pigment gallstone formation in germfree Swiss Webster mice.
Woods SE; Leonard MR; Hayden JA; Brophy MB; Bernert KR; Lavoie B; Muthupalani S; Whary MT; Mawe GM; Nolan EM; Carey MC; Fox JG
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G335-49. PubMed ID: 25477375
[TBL] [Abstract][Full Text] [Related]
10. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice.
Wang HH; Afdhal NH; Gendler SJ; Wang DQ
Gastroenterology; 2006 Jul; 131(1):210-22. PubMed ID: 16831603
[TBL] [Abstract][Full Text] [Related]
11. Relation of gallbladder motility to viscosity and composition of gallbladder bile in patients with cholesterol gallstones.
Gründel D; Jüngst C; Straub G; Althaus R; Schneider B; Spelsberg FW; Hüttl TP; del Pozo R; Jüngst D; Neubrand M
Digestion; 2009; 79(4):229-34. PubMed ID: 19390195
[TBL] [Abstract][Full Text] [Related]
12. Gallbladder motility and acute pancreatitis.
Pezzilli R
JOP; 2005 May; 6(3):279-80. PubMed ID: 15883482
[No Abstract] [Full Text] [Related]
13. Gallbladder dysfunction in diabetes mellitus.
Shaw SJ; Hajnal F; Lebovitz Y; Ralls P; Bauer M; Valenzuela J; Zeidler A
Dig Dis Sci; 1993 Mar; 38(3):490-6. PubMed ID: 8444081
[TBL] [Abstract][Full Text] [Related]
14. Relation of abnormal gallbladder arterioles to gallbladder emptying in patients with gallstone and diabetes mellitus.
Ding X; Gong JP; Lu CY; Liu CA; Shi YJ; Gao GW
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):275-8. PubMed ID: 15138125
[TBL] [Abstract][Full Text] [Related]
15. Decreased postprandial gallbladder emptying in patients with black pigment stones.
Sugo T; Hakamada K; Narumi S; Sasaki M
World J Gastroenterol; 2008 May; 14(18):2825-31. PubMed ID: 18473405
[TBL] [Abstract][Full Text] [Related]
16. Biliary symptoms, gallbladder motility, and cholecystectomy.
Colecchia A; Festi D
Hepatology; 2007 Jan; 45(1):259-60. PubMed ID: 17187423
[No Abstract] [Full Text] [Related]
17. Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review.
Koppisetti S; Jenigiri B; Terron MP; Tengattini S; Tamura H; Flores LJ; Tan DX; Reiter RJ
Dig Dis Sci; 2008 Oct; 53(10):2592-603. PubMed ID: 18338264
[TBL] [Abstract][Full Text] [Related]
18. Effect of intestinal transit on the formation of cholesterol gallstones in hamsters.
Fan Y; Wu SD; Fu BB
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):513-5. PubMed ID: 17897916
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
[TBL] [Abstract][Full Text] [Related]
20. The gallbladder: innocent bystander or major factor in cholesterol-gallstone formation?
van Erpecum KJ; Wang DQ
J Lab Clin Med; 2005 Oct; 146(4):202-4. PubMed ID: 16194680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
